Achieving a polio free world

BMC Medicine

David A Sack¹  Mohammad Ali¹ 

[1] Department of International Health, Johns Hopkins Bloomberg School of Public Health, 615 N.Wolfe Street / E5543, Baltimore 21205, Maryland, USA

关键词: OPV;    Risk area;    Spatial model;    Polio;   

Others  :  796665
DOI  :  10.1186/s12916-014-0116-3

 received in 2014-06-17, accepted in 2014-06-19,  发布年份 2014

【 摘 要 】

Recently, the World Health Organization (WHO) declared that the spread of polio is an international public health emergency, and a coordinated international response is sought. Although the importance of such a response is recognized, there are challenges to stopping the spread of polio and achieving a polio free world. The most important issue is directing limited national resources to the specific areas where polio is endemic. In an article published in BMC Medicine, Upfill-Brown and his colleagues recognized this problem and successfully identified the potential risk areas in Nigeria using a validated spatial predictive model of wild poliovirus circulation. They also showed that a lower vaccine-derived population immunity is associated with the probability of a higher number of wild poliovirus cases within a district. Identification of the potential risk areas and understanding the magnitude of risk may help direct limited resources of the endemic countries to areas most at risk to maximize the impact of interventions and motivate the people to participate in the intervention program. These efforts are crucial if these endemic countries hope to eradicate polio.

Please see related research article: http://www.biomedcentral.com/1741-7015/12/92 webcite.

【 授权许可】

   
2014 Ali and Sack; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Underwood M: A treatise of children with general directions for management of infants from birth. Matthews, London; 1789.
• [2]Immunologic classification of poliomyelitis viruses: a cooperation program for typing of one hundred strains Am J Hyg 1951, 54:191-274.
• [3]Dowdle WR, Birmingham ME: The biologic principles of poliovirus eradication. J Infect Dis 1997, 175:S286-S292.
• [4]Bancroft PM, Engelhard WE, Evans C: Poliomyelitis in Huskerville (Lincon) Nebraska: studies indicating a relationship between clinically severe infection and proximate fecal pollution of water. JAMA 1957, 164:836-847.
• [5]Aycock WL: A milk-borne epidemic of poliomyelitis. Am J Hyg 1927, 7:791-803.
• [6]Bernier RH: Some observations on poliomyelitis lameness surveys. Rev Infect Dis 1984, 6:S371-S375.
• [7]Sabin AM: Paralytic consequences of poliomyelitis infections in different parts of the world and in different population groups. Am J Public Health 1951, 41:1215-1230.
• [8]Moturi EK, Porter KA, Wassilak SGF, Tangermann RH, Diop OM, Burns CC, Jafari H: Progress toward polio eradication—worldwide, 2013–2014. Morb Mortal Wkly Rep 2014, 63:468-472.
• [9]WHO statement on the meeting of the International Health Regulations Emergency Committee concerning the international spread of wild poliovirus. World Health Organization; May 5 2014. ᅟ.
• [10]Upfill-Brown AM, Lyons HM, Pate MA, Shuaib F, Baig S, Hu H, Eckhoff PA, Chabot-Couture G: Predictive spatial risk model of poliovirus to aid prioritization and hasten eradication in Nigeria. BMC Med 2014, 12:92. BioMed Central Full Text
• [11]Grassly NC, Fraser C, Wenger J, Deshpande JM, Sutter RW, Heymann DL, Aylward RB: New strategies for the elimination of polio from India. Science 2006, 314:1150-1153.
• [12]Osazuwa-Peters N: Determinants of health disparities: the perennial struggle against polio in Nigeria. Int J Prev Med 2011, 2:117-121.
• [13]Renne E: Perspectives on polio and immunization in Northern Nigeria. Soc Sci Med 2006, 63:1857-1869.
• [14]Aylward B, Yamada T: The polio endgame. N Engl J Med 2011, 364:2273-2275.
• [15]Parashar UD, Glass RI: Rotavirus vaccines--early success, remaining questions. N Engl J Med 2009, 360:1063-1065.
• [16]John TJ: Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection. Am J Epidemiol 1975, 102:414-421.
• [17]Zaman K, Sack DA, Yunus M, Arifeen SE, Podder G, Azim T, Luby S, Breiman RF, Neuzil K, Datta SK, Delem A, Suryakiran PV, Bock HL: Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009, 27:1333-1339.
• [18]Rath B, Ali M, Elemuwa C, Maurer W, Bouder F, Mworozi E, Diedrich S, Khamesipour A, Seeber LD, Chitwood I, Kochhar S: Prioritizing polio. Expert Rev Vaccines 2012, 11:1389-1392.